INSIGHTS ON CONTRACT PHARMA MANUFACTURING

• Supporting A Company In Manufacturing The RSM For Treating A Rare Tumour

  A clinical-stage oncology company needed a partner to manufacture the RSM. Examine how an optimized RSM manufacturing process helped deliver safe, effective treatment on an accelerated timeline.

• The Growth Of Sterile Injectables

  Partnering with a manufacturer capable of delivering flexible aseptic fill-finish solutions for both small and large-scale production runs is essential for delivering products to patients safely and efficiently.

• Detection And Quantification Of Process-Related Impurities

  Finding a partner with the expertise and capabilities to provide solutions for detecting and quantifying process-related impurities ensures the successful development and manufacturing of safe and effective products.

• High Potent Formulation Development In Oncology

  Examine the vital role formulation development plays in oncology outsourcing and how sponsors can increase their chances of success with the right CDMO partner.

• Pharma Research, Development, And Launches Saves Lives — And The Earth

  Discover how a defined framework and way of measuring allows companies to align priorities, short- or long-term goals, and what ESG success looks like in terms of tangible measurements.

• CDMO Management for Sponsors — Part 2: Handling SOPs, Multiple Partnerships, and M&A Disruptions

  Day-to-day discussions between technical teams and regular brainstorming/exchange-of-information meetings are commonly understood to be vital to a partnership — ensuring the sponsor and vendor understand each other’s long- and short-term priorities — but problem-solving and mediation are equally critical communication skills.

• CDMO Management for Sponsors — Part 1: Identify Partners and Nail Project Kickoff

  Identifying an appropriate CDMO partner and establishing relationship structure/expectations early is an intrinsic part of leveraging the CDMO to provide the sponsor a competitive advantage. A good partner blurs the line between third-party service and extension of your company.

• Streamlining Viral Vector Development And Manufacturing For Gene Therapies

  Learn about MilliporeSigma's capabilities and solutions for gene therapy production as experts highlight key features of their technologies and infrastructure through a virtual tour of the GMP manufacturing facility.

• Get To The GMP Clinical Stage Quickly Utilizing Scale Down Models

  Explore how scale-down models can shorten timelines, accelerate process development, and advance your novel therapy to the GMP clinical stage with speed and reduced costs.

• Conduits Of Industry Intel

  Martin Lehr, CEO, Context Therapeutics, explains a key role of consultants – one that should be utilized more – is that of information and intelligence sources for what is happening throughout our industry.